The European Union granted Shanghai MicroPort EP MedTech (SHA:688351) a medical device regulation certificate for its cryoablation catheter, according to a Wednesday filing with the Shanghai bourse.
The product, branded IceMagic, is indicated for cryoablation or the use of extreme cold to treat atrial fibrillation or irregular heartbeat, according to the filing.
The certificate is valid for five years from July 16, 2025 to July 15, 2030.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.